BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 18545147)

  • 1. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN; Dyck R; Weenig RH; Comfere NI
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spindle cell neoplasm of skin: diagnostic dilemma.
    Jain M; Singh S; Agarwal K
    Indian J Pathol Microbiol; 2007 Oct; 50(4):814-6. PubMed ID: 18306566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
    Clarke LE; Frauenhoffer E; Fox E; Neves R; Bruggeman RD; Helm KF
    J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procollagen 1 expression in atypical fibroxanthoma and other tumors.
    Jensen K; Wilkinson B; Wines N; Kossard S
    J Cutan Pathol; 2004 Jan; 31(1):57-61. PubMed ID: 14675286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value.
    Monteagudo C; Calduch L; Navarro S; Joan-Figueroa A; Llombart-Bosch A
    Am J Clin Pathol; 2002 Jan; 117(1):126-31. PubMed ID: 11789717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical fibroxanthoma with keloidal collagen.
    Fussell JN; Cooke ER; Florentino F; Sheehan DJ
    Am J Dermatopathol; 2010 Oct; 32(7):713-5. PubMed ID: 20700041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
    Dotto JE; Glusac EJ
    J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical fibroxanthoma: a clinicopathological study of 89 cases.
    Mirza B; Weedon D
    Australas J Dermatol; 2005 Nov; 46(4):235-8. PubMed ID: 16197421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keloidal atypical fibroxanthoma: a case series.
    Kim J; McNiff JM
    J Cutan Pathol; 2009 May; 36(5):535-9. PubMed ID: 19476521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleomorphic spindle cell dermal neoplasm with dot-like keratin reactivity: keratin-positive AFX or carcinoma?
    Ellis R; Chase E; Barland A; Rajpara A; Fraga GR
    J Cutan Pathol; 2015 Nov; 42(11):847-52. PubMed ID: 26041010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical fibroxanthoma with lymphomatoid reaction.
    Zheng R; Ma L; Bichakjian CK; Lowe L; Fullen DR
    J Cutan Pathol; 2011 Jan; 38(1):8-13. PubMed ID: 21039743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.